<p>In the first 100 days of opt out testing over 250,000 HIV tests and over 100,000 hepatitis C virus antibody tests were delivered from April to July 2022. This testing resulted in identification of more than 500 people with a previously unknown (unrecognised or undiagnosed) blood borne virus. The full report can be found at the following link:</p><p><a href="https://www.england.nhs.uk/long-read/emergency-department-opt-out-testing-for-hiv-hepatitis-b-and-hepatitis-c-the-first-100-days/" target="_blank">https://www.england.nhs.uk/long-read/emergency-department-opt-out-testing-for-hiv-hepatitis-b-and-hepatitis-c-the-first-100-days/</a></p><p>NHS England and the UK Health Security Agency will publish reports evaluating the impact of the first year of opt-out HIV and blood borne virus testing in 2023. We will consider all the evidence from the first year of opt-out testing alongside the data on progress towards our ambitions to end new HIV transmissions and AIDS- and HIV-related deaths within England by 2030 when examining the feasibility for further expansion of this programme.</p><p>We will be sharing evidence as it emerges to support other areas to make the case locally for implementing the same approach in other areas of the country.</p>